Riskpilot← Back to searchSign inGet full accessHilpen Orolynx AB
ABActiveOrg 5594121013Bladvägen 22Medical specialists activities · NACE 8622Est. 20220 employees
Revenue 2025
—
EBITDA margin
—
-310% vs 2024
Equity ratio
53.0%
Financial strength
Net profit 2025
SEK 218K
+62% vs 2024
| Revenue | — | — |
| EBITDA | SEK -21K | -310% |
| Net profit | SEK 218K | +62% |
| Total assets | SEK 712K | +77% |
| Equity | SEK 378K | +137% |
| Employees | 0 | — |
Legal name
Hilpen Orolynx AB
Org number
5594121013
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
13 december 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-05-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska äga och förvalta aktier och andra värdepapper där bolaget ägarandel och kapitalandel ej får överstiga 50 procent samt även äga och förvalta fastigheter och bostadsrätter. Bolaget kommer även att hyra ut specialistläkare gällande konsultation och behandling.
Address
Bladvägen 22
Email
hillevi.pendleton@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 | 2025 |
|---|---|---|
| Revenue | — | — |
| Staff expenses | — | — |
| EBITDA | −5 | −21 |
| Depreciation & amort. | — | — |
| EBIT | −5 | −21 |
| Net financials | 140 | 239 |
| Profit before tax | 135 | 218 |
| Tax | — | — |
| Net profit | 135 | 218 |
| Item | 2024 | 2025 |
|---|---|---|
| Total assets | 402 | 712 |
| Equity | 160 | 378 |
| Long-term debt | — | — |
| Short-term debt | 242 | 335 |
| Total debt | 242 | 335 |
EBITDA margin
-2050700.0%
This company
15.8%
Market median
-12979214% vs market
20242025
Equity ratio
53.0%
This company
38.2%
Market median
+39% vs market
20242025
Return on equity
57.7%
This company
18.4%
Market median
+214% vs market
20242025
Net profit margin
21819300.0%
This company
8.1%
Market median
+269373974% vs market
20242025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20242025
Debt / equity
0.89×
This company
0.62×
Market median
+44% vs market
20242025
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EJ Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hilpen Orolynx AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Jonas Huléen | Audit | 0 companies |
| Hillevi Susanne Pendleton | Board of Directors | 0 companies |
| Sven Christian Olsson Pendleton | Deputy Board Member | 0 companies |